Hilfe zu Eingabehilfen | Sitemap | Kontaktieren Sie uns | Kundendienst ANRUF: 01/86330
Österreich Change Country
Startseite  |  Einsatzgebiete  |  Produkte  |  Klinische Evidenz  |  Fortbildung and Training  |  Für Patienten  |  Kundendienst
Sie sind hier: Startseite > Nachrichten & Medien > Acelity Increases Focus on Growth, Expansion Opportunities
Drucken

Acelity Increases Focus on Growth, Expansion Opportunities

Freigegeben : 30 November 2015

 Appoints Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing

KCI, Leader in Advanced Wound Care Solutions

SAN ANTONIO, November 30, 2015 – Acelity L.P. Inc. announced today the appointment of Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing (SBD&L). Dennis joins Acelity as a member of the senior leadership team. 

 

In this position, Dennis will oversee strategic planning, portfolio management and business development including M&A, partnerships, alliances and other activities that support Acelity’s growth strategy. Dennis brings to Acelity more than 20 years of experience in guiding mergers and acquisitions, joint ventures and strategic affiliations in all regions of the world. His deep expertise in corporate transactions and demonstrated leadership abilities make him especially well-suited to working across countries and franchises to identify and aggressively pursue opportunities on behalf of Acelity.

 

“We have achieved significant results against our strategic imperative as we seek to establish Acelity as a global leader in medical technology,” said Joe Woody, President and CEO, Acelity. “As Acelity enters the next phase of its transformative journey, Dennis’ proven track record in leading business development and strategy make him a natural fit to drive and execute on our vision for growth in business segments and geographies around the world.”

 

Dennis joins Acelity from Medtronic and led previously the Covidien Global Business Development team prior to that merger, supporting business units and geographies while identifying new market opportunities. He is a graduate of Harvard College with a degree in Economics.

 

About Acelity

Acelity L.P. Inc. and its subsidiaries are a global advanced wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,700 people around the world.

 

For more information, contact:

Cheston Turbyfill
Corporate Communications
Phone: +1-210-515-7757
Email: cheston.turbyfill@acelity.com
 
Caleb Moore
Investor Relations
Phone: +1-210-255-6433
Email: caleb.moore@acelity.com

 


  • Share on Facebook.com
  • Share on Twitter
  • Besuchen Sie unsere YourTube Seite

Wichtige Mitteilung für Patienten

Rechtliches | Datenschutzrichtlinien | Kontaktieren Sie uns | Impressum


© 1998 - 2013 KCI Licensing, Inc. Alle Rechte vorbehalten.    DSL# 09-03-193.AT
Die Informationen auf dieser Website wurden ausschließlich zur Nutzung in Österreich/ KCI Austria GmbH bereitgestellt. Diese Website enthält Informationen über Produkte, die möglicherweise nicht in allen Ländern verfügbar sind. Es ist außerdem möglich, dass sie von den zuständigen Behörden in bestimmten Ländern noch nicht oder nicht für bestimmte Indikationen zugelassen sind.